Exelixis (EXEL) Interest Coverage Ratio (2010 - 2026)
Exelixis (EXEL) posted quarterly Interest Coverage Ratio of 128.37 for Q2 2026, down 34.19% year-over-year from 195.05 in Q2 2025, and down 97.93% quarter-over-quarter from 6189.89 in Q1 2026.
Exelixis (EXEL) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Exelixis' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 128.37 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio fell 34.19% year-over-year to 128.37; the TTM figure through Apr 2026 stood at 478.38 (down 39.86% YoY), while the FY2026 annual figure was 9.95, up 41.49% from the prior year.
- Interest Coverage Ratio for Q2 2026 stood at 128.37, down from 6189.89 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 6189.89 in Q1 2026, with the low at 0.98 in Q3 2023.
- The 5-year median for Interest Coverage Ratio is 7.33 (2022), against an average of 593.6.
- The sharpest annual moves came in 2023 and 2026: Interest Coverage Ratio tumbled 126.49% in 2023, then soared 326071.19% in 2026.
- Exelixis' Interest Coverage Ratio stood at 0.62 in 2022, then soared by 258.29% to 0.99 in 2023, then soared by 11918.4% to 118.43 in 2024, then soared by 2493.91% to 3071.95 in 2025, then slumped by 95.82% to 128.37 in 2026.
- Business Quant data shows EXEL's Interest Coverage Ratio at 128.37 in Q2 2026, 6189.89 in Q1 2026, and 3071.95 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Exelixis | 12.75 Bn | 11.91 Bn | 608.03 Mn | 81.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 81.18 |
| Apr 3, 2026 | 128.37 |
| Jan 2, 2026 | 6,189.89 |
| Oct 3, 2025 | 3,071.95 |
| Jul 4, 2025 | 313.62 |
| Apr 4, 2025 | 195.05 |
| Jan 3, 2025 | 1.90 |
| Sep 27, 2024 | 118.43 |
| Jun 28, 2024 | 41.31 |
| Mar 29, 2024 | 4.14 |
| Dec 29, 2023 | 0.99 |
| Sep 29, 2023 | -0.98 |
| Jun 30, 2023 | 4.20 |
| Mar 31, 2023 | 2.02 |
| Dec 30, 2022 | -0.62 |
| Sep 30, 2022 | 3.70 |
| Jul 1, 2022 | 7.33 |
| Apr 1, 2022 | 9.84 |
| Dec 31, 2021 | 2.68 |
| Oct 1, 2021 | 406.46 |